Back to User profile » Dr Emrah Yildiz

Paper published by Dr Emrah Yildiz:


Original Research

Serum NOX1 and Raftlin as New Potential Biomarkers of Interest in Schizophrenia: A Preliminary Study

Hurşitoğlu O, Kurutas EB, Strawbridge R, Uygur OF, Yildiz E, Reilly TJ

Neuropsychiatric Disease and Treatment 2022, 18:2519-2527

Published Date: 2 November 2022